FDA Approves Ocrelizumab for Pediatric Relapsing MS
-
The FDA approval makes ocrelizumab a new treatment option for children aged
10 years and older with relapsing-remitting multiple sclerosis.
*Medscape Medic...
1 day ago
No comments:
Post a Comment